drugset
drugset / Trial / NCT03009760

To Investigate Pharmacokinetics and Pharmacodynamics of CJ-12420 After Single and Multiple Dose Administration

NCT03009760 ↗

Phase 1 Completed 16 enrolled HK inno.N Corporation Asan Medical Center · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the pharmacokinetics and pharmacodynamics of CJ-12420 after single and multiple dose administration according to H. pylori infection.

Timeline

Start
2015-01
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Tegoprazan Other / unclassified 50 mg —
Subject Tegoprazan Other / unclassified 100 mg —

Indications

No indication recorded.